Dermatology Clinical Trials

Recruiting dermatology studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat dermatology. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting dermatology studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting dermatology trials

Within

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

for Atopic Dermatitis

1 site in Boston

Sponsor: Boston Children's Hospital

Sex: All·Age: 6+

Code: NCT06397781·Phase 4

Combination Immunotherapy Targeting Melanoma

for Melanoma

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 18 - 75

Code: NCT06739226·Phase 1, Phase 2

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Enzychem Lifesciences Corporation

Sex: All·Age: 19 - 79

Code: NCT06487000·Phase 2

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

for Squamous Cell Carcinoma

1 site in Chicago

Sponsor: University of Chicago

Sex: All·Age: 18+

Code: NCT07346196·Phase 2

Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions

for Squamous Cell Carcinoma

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07631013·Phase 1

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

for Melanoma

1 site in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 55+

Code: NCT07704918

Apply to this trial

Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers

for Systemic Lupus Erythematosus

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 4 - 75

Code: NCT07791199·Phase 3

A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India

for Unresectable Melanoma

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 12+

Code: NCT07459543·Phase 4

An AI-Based Erythema Measurement System for Psoriasis Lesions

for Psoriasis

Sponsor: Khon Kaen University

Sex: All·Age: 18 - 100

Code: NCT07494396

Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor

for Melanoma

1 site in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07660666

Assessing Psoriasis Treatment Outcomes

for Psoriasis

1 site in Winston-Salem

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT07391423

A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All·Age: 18 - 75

Code: NCT07754786·Phase 3

A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07690319

A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With Psoriasis

for Psoriasis

Sponsor: Xantho Biotechnology Co., LTD

Sex: All·Age: 20+

Code: NCT06620692·Phase 2

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

for Squamous Cell Carcinoma

1 site in Charleston

Sponsor: Medical University of South Carolina

Sex: All·Age: 18+

Code: NCT07513389·Phase 2

Apply to this trial

Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

for Ankylosing Spondylitis

Sponsor: Assiut University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07648836

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

for Metastatic Melanoma

1 site in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+

Code: NCT07281924·Phase 1, Phase 2

Apply to this trial

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

for Gastrointestinal Neoplasms

1 site in Indianapolis

Sponsor: Indiana University

Sex: All·Age: 18+

Code: NCT07389525·EARLY_Phase 1

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

for Chronic Dermatological Conditions

Sponsor: National University Hospital, Singapore

Sex: All·Age: 16+

Code: NCT07481019

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

for Melanoma

Sponsor: Swiss Cancer Institute

Sex: All·Age: 18+

Code: NCT07574047·Phase 2

Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)

for Atopic Dermatitis

Sponsor: AbbVie

Sex: All·Age: 18 - 64

Code: NCT07741838

Mediterranean Dietary Intervention for HS

for Hidradenitis Suppurativa

1 site in Chapel Hill

Sponsor: University of North Carolina, Chapel Hill

Sex: All·Age: 18+

Code: NCT07800416

Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Galderma R&D

Sex: All·Age: 12+

Code: NCT07762833·Phase 3

A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT07454889

A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

for Psoriasis

Sponsor: Janssen-Cilag Kft.

Sex: All·Age: 18+

Code: NCT07746583

Apply to this trial

Impact of Dysport on PMFF Donor Scar

for Skin Cancer Excision Site

1 site in Nashville

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18+

Code: NCT07720726·Phase 4

Clinical Genetics Branch Eligibility Screening Survey

for Melanoma

1 site in Rockville

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 1 - 99

Code: NCT07005297

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

for Hyper IgE Syndrome From STAT3 Mutation

1 site in Bethesda

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 12 - 120

Code: NCT07262983·Phase 1

Apply to this trial

Natural History Study of Early Life Exposures in Agriculture (ELEA)

for Prostate Cancer

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 99·Accepts healthy volunteers

Code: NCT07328516

Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis

Sponsor: QuantX Biosciences, Inc.

Sex: All·Age: 18 Months - 65·Accepts healthy volunteers

Code: NCT07800104·Phase 1

Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Pontificia Universidad Catolica de Chile

Sex: All·Age: 0 Days+·Accepts healthy volunteers

Code: NCT07333378

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

for Melanoma

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07511036·Phase 2

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

for Melanoma

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07444606·Phase 1

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

for Melanoma

Sponsor: Biocon Biologics UK PLC

Sex: All·Age: 18+

Code: NCT07476326·Phase 1

The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health

for Preterm Birth

Sponsor: GrowBaby Life Project

Sex: Female·Age: 18+

Code: NCT07559773

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

for HPV Positive Oropharyngeal Squamous Cell Carcinoma

Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All·Age: 18+

Code: NCT07578467·Phase 1, Phase 2

Opzelura Experience Study

for Atopic Dermatitis

1 site in Winston-Salem

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 2+

Code: NCT07661979·Phase 4

Efficacy and Tolerability of a Probiotic Ointment

for Atopic Dermatitis

Sponsor: BioGaia AB

Sex: All·Age: 6 Months - 15

Code: NCT07701447

A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

for Psoriasis

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Sex: All·Age: 18 - 75

Code: NCT07724366·Phase 3

Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

for HNSCC,Larynx, Pharynx and Oral Cavity

Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All·Age: 18+

Code: NCT07741643·Phase 1

Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy

for Melanoma

Sponsor: Institute of Oncology Ljubljana

Sex: All·Age: 18+

Code: NCT07761871

Apply to this trial

A Study Evaluating TRIV-573 in Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Triveni Bio

Sex: All·Age: 18 - 75

Code: NCT07782333·Phase 2

Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma

for Metastatic Melanoma

Sponsor: European Institute of Oncology

Sex: All·Age: 18+

Code: NCT07794501

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

for Atopic Dermatitis

1 site in Tulsa

Sponsor: Pfizer

Sex: All·Age: 12+

Code: NCT07783425·Phase 3

Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis

for Psoriasis

Sponsor: Cairo University

Sex: All·Age: 18 - 60

Code: NCT07713212·Phase 4

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

for Atopic Dermatitis

2 sites in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 12 - 17

Code: NCT07746427

Apply to this trial

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

for Atopic Dermatitis

Sponsor: Pfizer

Sex: All·Age: 12+

Code: NCT07765888·Phase 3

A Phase 1 Study to Evaluate the Safety and Effects of a Single Dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults.

for Psoriasis

Sponsor: Shanghai Peptidstar Therapeutics Limited

Sex: All·Age: 18 - 45·Accepts healthy volunteers

Code: NCT07792928·Phase 1

Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial

for Melanoma

Sponsor: Herlev Hospital

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT05004792

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

for Melanoma

Sponsor: Alvotech Swiss AG

Sex: All·Age: 18+

Code: NCT07475572·Phase 1

Apply to this trial

Timing of Immunotherapy in Melanoma

for Melanoma

Sponsor: Radboud University Medical Center

Sex: All·Age: 18+

Code: NCT07696715

Apply to this trial

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

for Psoriasis

1 site in Chapel Hill

Sponsor: Janssen Research & Development, LLC

Sex: Female·Age: 18+

Code: NCT07654751·Phase 4

Apply to this trial

Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis

for Psoriasis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Sex: All·Age: 18+

Code: NCT07719530·Phase 2

Apply to this trial

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

for Psoriasis

1 site in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT07352566·Phase 4

Nailfold Capillaroscopic Changes in Psoriasis

for Psoriasis

Sponsor: Al-Azhar University

Sex: All·Age: All ages

Code: NCT07693595

Apply to this trial

Azithromycin in Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Cairo University

Sex: All·Age: 3 - 12

Code: NCT07713186·Phase 4

Anti Inflammatory Diet With Physical Therapy on Psoriasis

for Psoriasis

Sponsor: Mahmoud Usama Mahmoud Ahmed

Sex: All·Age: 6 - 17

Code: NCT07736651

Apply to this trial

A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Bionyra Pharma

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07746817·Phase 1

An Observational Study of Patients With Dermatologic Disease

for Vitiligo

3 sites incl. Winston-Salem

Sponsor: Target PharmaSolutions, Inc.

Sex: All·Age: All ages

Code: NCT07748169

Apply to this trial

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

for Melanoma

1 site in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT06365619·Phase 2

Apply to this trial

New trials in Birmingham, AL?

Pick a condition and we'll email you once a week when a new study starts recruiting in Birmingham, AL. Unsubscribe anytime.

Dermatology clinical trials — common questions

Are dermatology clinical trials free to join?

Yes. Participating in a dermatology clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a dermatology clinical trial?

Each dermatology study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a dermatology trial near me?

Use the location controls above. We'll show recruiting dermatology trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many dermatology trials are recruiting right now?

We're currently tracking roughly 325 recruiting dermatology trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Dermatology trials by city

Birmingham, AL Boston, MA Los Angeles, CA San Francisco, CA Columbus, OH Duarte, CA Sacramento, CA Tampa, FL Chicago, IL La Jolla, CA Orange, CA Ann Arbor, MI

Conditions in this area

Psoriasis Atopic dermatitis / eczema Hidradenitis suppurativa Melanoma Skin cancer